What's new

What criteria should you consider when developing reliable and translationally relevant disease models from edited hiPSCs?


Takara Bio USA, Inc. announced today that its parent company, Takara Bio Inc., submitted a Drug Master File to the Food and Drug Administration for the liquid formulation of RetroNectin GMP grade on March 15, 2019.


Discover how researchers used the powerful, new CUT&Tag method and ICELL8 technology for high-throughput, single-cell profiling of chromatin components.


Researchers from Steven Henikoff's laboratory (Fred Hutchinson Cancer Research Center) have developed a novel epigenomic method, CUT&Tag (Cleavage Under Targets and Tagmentation), for high-throughput profiling of chromatin components in single cells on the ICELL8 Single-Cell System.


Featured information

In this webinar, Dr. Nathalie Bolduc (Takara Bio USA, Inc.) presents data from the SMARTer Stranded Total RNA-Seq Kit v2 - Pico Input Mammalian, which generates Illumina-ready sequencing libraries from 250 pg–10 ng mammalian total RNA inputs of any quality, including FFPE samples.

Our start-to-finish editing and single-cell cloning kits make human iPS cell editing routine instead of frustrating. In this video protocol, we provide step-by-step instructions for generating edited human iPS cell lines using our complete system for electroporation-based delivery of RNP complexes and single-cell cloning. This high-efficiency workflow greatly improves single-cell survival post-seeding, thanks to the Cellartis DEF-CS culture system. In addition to our electroporation-based kit, we also offer an alternate kit that uses gesicles to deliver RNP complexes.